- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Construction Boom
U.S. Pharmaceuticals & Biotech Construction Boom
UPDATED Mar 19, 2024
Highly cyclical companies in construction-related industries with a strong future outlook.
66 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
TGTX | US$15.37 | -2.3% | 7.9% | US$2.2b | US$29.75 | PE175.6x | E49.9% | n/a | ||
AMRN | US$0.87 | 0.3% | -46.5% | US$356.3m | US$1.08 | PS1.2x | E51.2% | n/a | ||
ARCT | US$33.76 | -12.7% | 119.2% | US$908.7m | US$67.89 | PS5.4x | E58.7% | n/a | ||
MDXG | US$8.20 | 3.1% | 138.4% | US$1.2b | US$12.52 | PE21.6x | E15.7% | n/a | ||
HALO | US$40.38 | -2.3% | 22.9% | US$5.2b | US$50.70 | PE18.2x | E20.8% | n/a | ||
AXSM | US$78.85 | 12.8% | 25.2% | US$3.6b | US$119.75 | PS13.8x | E60.1% | n/a | ||
MIRM | US$26.99 | -2.8% | 21.3% | US$1.3b | US$49.00 | PS6.8x | E63.2% | n/a | ||
SPPI | US$1.03 | 5.3% | 17.0% | US$209.9m | US$1.26 | PS8.2x | E67.3% | n/a | ||
AUPH | US$5.18 | -0.4% | -43.8% | US$749.1m | US$10.57 | PS4.3x | E53.7% | n/a | ||
AVDL | US$16.57 | 3.0% | 91.3% | US$1.4b | US$22.90 | PS53.7x | E56.7% | n/a | ||
CDXC | US$3.06 | 45.7% | 100.0% | US$204.5m | US$5.73 | PS2.8x | E93.2% | n/a | ||
ALDX | US$2.92 | 0.7% | -63.8% | US$167.9m | US$9.40 | PB1.4x | E51.9% | n/a | ||
GTHX | US$3.45 | -0.3% | 21.1% | US$171.2m | US$8.50 | PS2.2x | E55.1% | n/a | ||
DVAX | US$12.10 | -0.6% | 25.8% | US$1.6b | US$24.67 | PS6.8x | E41.6% | n/a | ||
EXAS | US$62.66 | 2.6% | -2.4% | US$11.2b | US$88.49 | PS4.6x | E61.5% | n/a | ||
PTGX | US$28.82 | -3.5% | 26.7% | US$1.7b | US$43.00 | PS28x | E48.8% | n/a | ||
SNDL | US$1.53 | 14.2% | 2.0% | US$388.1m | US$3.65 | PB0.4x | E62.2% | n/a | ||
AMRX | US$6.08 | 12.6% | 337.4% | US$1.9b | US$7.31 | PB94.4x | E132.7% | 0% | ||
MEDP | US$399.05 | -2.2% | 123.2% | US$12.0b | US$389.50 | PE43.4x | E14.6% | n/a | ||
TLRY | US$1.98 | 18.6% | -23.0% | US$1.4b | US$2.58 | PS2.1x | E115.9% | n/a | ||
RCEL | US$16.15 | -5.5% | 21.8% | US$413.3m | US$26.49 | PS8.3x | E64.0% | n/a | ||
ZVRA | US$6.04 | -3.8% | 11.6% | US$246.8m | US$18.25 | PS15.1x | E59.5% | n/a | ||
CAPR | US$6.85 | 15.3% | 60.0% | US$213.2m | US$21.00 | PS8.5x | E59.4% | n/a | ||
HBIO | US$4.40 | 0.2% | 46.2% | US$191.0m | US$7.00 | PS1.7x | E98.9% | n/a |